REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 112 filers reported holding REPLIMUNE GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $48,858,000 | -9.1% | 2,122,415 | -1.9% | 4.55% | -19.1% |
| Q2 2020 | $53,741,000 | +89.9% | 2,162,598 | -23.8% | 5.63% | +17.6% |
| Q1 2020 | $28,305,000 | -30.5% | 2,838,968 | 0.0% | 4.79% | -21.2% |
| Q4 2019 | $40,739,000 | +3.2% | 2,838,968 | 0.0% | 6.08% | -40.2% |
| Q3 2019 | $39,462,000 | -5.2% | 2,838,968 | 0.0% | 10.16% | -51.9% |
| Q2 2019 | $41,619,000 | -3.7% | 2,838,968 | 0.0% | 21.14% | +22.4% |
| Q1 2019 | $43,209,000 | +52.2% | 2,838,968 | 0.0% | 17.28% | +78.1% |
| Q4 2018 | $28,390,000 | -37.9% | 2,838,968 | 0.0% | 9.70% | -6.5% |
| Q3 2018 | $45,707,000 | – | 2,838,968 | – | 10.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,001,319 | $51,352,568 | 47.17% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $35,901,913 | 5.56% |
| Redmile Group, LLC | 4,163,922 | $71,244,705 | 3.39% |
| Nan Fung Group Holdings Ltd | 184,739 | $3,160,884 | 2.56% |
| GREAT POINT PARTNERS LLC | 638,495 | $10,924,649 | 1.99% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $2,566,500 | 1.72% |
| Ghost Tree Capital, LLC | 250,000 | $4,277,500 | 1.41% |
| Altium Capital Management LP | 155,000 | $2,652,050 | 1.38% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,766,000 | 1.18% |
| Camber Capital Management LP | 2,000,000 | $34,220 | 1.13% |